Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 16 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact16 DOIs

Deposit reference lists for 2 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 164 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Dual Approaches in Oncology: The Promise of siRNA and Chemot… (10.3390/onco5010002)	ORCID	36.56	28
2	Decoding the Oncogenic Signals from the Long Non-Coding RNAs (10.3390/onco1020014)	ORCID	32.53	19
3	Role of NK Cells in Cancer and Immunotherapy (10.3390/onco1020013)	ORCID	22.58	7
4	Akt/mTOR Activation in Lung Cancer Tumorigenic Regulators an… (10.3390/onco2010004)	ORCID	21.13	6
5	When Therapy-Induced Cancer Cell Apoptosis Fuels Tumor Relap… (10.3390/onco4010003)	ORCID	21.13	6
6	Revisiting the Role of PD-L1 Overexpression in Prognosis and… (10.3390/onco4030011)	ORCID	21.13	6
7	Significance of PET/CT Imaging in Myeloma Assessment: Explor… (10.3390/onco4010002)	ORCID	19.45	5
8	Core Needle Biopsy Enhances the Activity of the CCL2/CCR2 Pa… (10.3390/onco2010001)	ORCID	15.05	3
9	State of the Art on CAR T-Cell Therapies for Onco-Haematolog… (10.3390/onco4030017)	ORCID	15.05	3
10	Pre-Clinical Research Advancements Relating to Improving the… (10.3390/onco1020006)	ORCID	7.53	1
11	Targeting Abnormal Cell Cycle in Cancer: A Preface to the Sp… (10.3390/onco2010003)	ORCID	7.53	1
12	Exploring the Potential of Biotics in Cancer Prevention and… (10.3390/onco5030041)	ORCID	7.53	1
13	Synthetic Inhibitors of CDK4/6 Activities and Tumor Suppress… (10.3390/onco1010001)		0.00	0
14	The Impact of Immune Checkpoint-Inhibitors Therapy in Urinar… (10.3390/onco1010002)		0.00	5
15	Do We Really Need Another Oncology Journal? (10.3390/onco1010003)	References	0.00	0
16	Targeting HMGB1 in the Treatment of Non-Small Cell Lung Aden… (10.3390/onco1010004)		0.00	4
17	Clinical Application of Next-Generation Sequencing in Recurr… (10.3390/onco1010005)		0.00	1
18	Assessment of a Nano-Docetaxel Combined Treatment for Head a… (10.3390/onco1020007)		0.00	2
19	Tumor-Agnostic Biomarkers: Heed Caution, and Why Cell of Ori… (10.3390/onco1020008)		0.00	2
20	Tumor Cell Secretomes in Response to Anti- and Pro-Tumorigen… (10.3390/onco1020009)		0.00	5
21	Pre-Treatment C-Reactive Protein Predicts Survival in Small… (10.3390/onco1020010)		0.00	5
22	Radiotheranostic Agents Targeting Neuroblastoma: State-of-th… (10.3390/onco1020011)		0.00	2
23	Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastr… (10.3390/onco1020012)		0.00	0
24	Yttrium-90 Internal Radiation Therapy as Part of the Multimo… (10.3390/onco1020015)		0.00	1
25	Open Data to Support CANCER Science—A Bioinformatics Perspec… (10.3390/onco1020016)		0.00	1
26	Optimizing the Pharmacological and Optical Dosimetry for Pho… (10.3390/onco2010002)		0.00	8
27	Sparse-Input Neural Networks to Differentiate 32 Primary Can… (10.3390/onco2020005)		0.00	4
28	Angiodrastic Chemokines Production by Colonic Cancer Cell Li… (10.3390/onco2020006)		0.00	1
29	Profiling of the Prognostic Role of Extracellular Matrix-Rel… (10.3390/onco2020007)		0.00	2
30	Evaluation of miRNA Expression in Glioblastoma Stem-Like Cel… (10.3390/onco2020008)		0.00	3
31	Whole Genome Variant Dataset for Enriching Studies across 18… (10.3390/onco2020009)		0.00	1
32	Fucoxanthinol Promotes Apoptosis in MCF-7 and MDA-MB-231 Cel… (10.3390/onco2030010)		0.00	6
33	The Role of Immune Checkpoint Blockade in Acute Myeloid Leuk… (10.3390/onco2030011)		0.00	2
34	The Role of Liquid Biopsy in the Diagnostic Testing Algorith… (10.3390/onco2030012)		0.00	4
35	Genomic and Gene Expression Studies Helped to Define the Het… (10.3390/onco2030013)		0.00	4
36	Augmented Expression of the IL3RA/CD123 Gene in MLL/KMT2A-Re… (10.3390/onco2030014)		0.00	4
37	The Dependence of Compensation Dose on Systematic and Random… (10.3390/onco2030015)		0.00	1
38	ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeuti… (10.3390/onco2040016)		0.00	6
39	Gene Screening in High-Throughput Right-Censored Lung Cancer… (10.3390/onco2040017)		0.00	0
40	Review of Template-Based Neuroimaging Tools in Neuro-Oncolog… (10.3390/onco3010001)		0.00	3
41	Regulation of Epithelial–Mesenchymal Transition Pathway and… (10.3390/onco3010002)		0.00	5
42	Risk Factors and Prevention of Gastric Cancer Development—Wh… (10.3390/onco3010003)		0.00	5
43	Fractionated Volumetric Modulated Arc Therapy (FVMAT) for Ol… (10.3390/onco3010004)		0.00	0
44	The Chart Diagnostic System Improves the Diagnostic Accuracy… (10.3390/onco3010005)		0.00	1
45	CT Radiomics and Clinical Feature Model to Predict Lymph Nod… (10.3390/onco3020006)		0.00	3
46	Transcriptome Analysis Identifies Tumor Immune Microenvironm… (10.3390/onco3020007)		0.00	0
47	A Comprehensive Review on the Role of Human Epidermal Growth… (10.3390/onco3020008)		0.00	11
48	Onco: A Promising Player Amidst Oncology Journals (10.3390/onco3020009)	References	0.00	0
49	Precision Medicine Revolutionizing Esophageal Cancer Treatme… (10.3390/onco3030010)		0.00	6
50	NUP98 Rearrangements in AML: Molecular Mechanisms and Clinic… (10.3390/onco3030011)		0.00	12